1. Morel J, Miossec P, Combe B. Immunopathologie de la polyarthrite rhumatoïde. In: Encyclopédie Médico-Chirurgicale, Appareil locomoteur tome 4. Paris : Elsevier Masson SAS ; 2004. 14220-A-15: 8 p.
2. Adalimumab, a fully human anti-tumour necrosis factor-α monoclonal antibody, and concomitant standard antirheumatic therapy for treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid arthritis);Furst;J Rheumatol,2003
3. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of multicenter, randomized, double-blind, placebo-controlled trial;Van der Heijde;Arthritis Rheum,2006
4. Efficacy and safety results from the randomized controlled comparative study of adalimumab versus methotrexate versus placebo in patients with psoriasis;Saurat;Br J Dermatol,2008
5. Efficacy and safety of adalimumab in Crohn's disease;Lichtenstein;Ther Adv Gastroenterol,2008